Northwest Investment Counselors’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $30K | Buy |
+100
| New | +$30K | 0.01% | 297 |
|
|
2024
Q2 | – | Sell |
-100
| Closed | -$39.6K | – | 505 |
|
|
2024
Q1 | $39.6K | Buy |
+100
| New | +$39.6K | 0.01% | 253 |
|
|
2023
Q4 | – | Sell |
-100
| Closed | -$37.5K | – | 549 |
|
|
2023
Q3 | $37.5K | Hold |
100
| – | – | 0.01% | 255 |
|
|
2023
Q2 | $38.2K | Hold |
100
| – | – | 0.01% | 263 |
|
|
2023
Q1 | $34.6K | Hold |
100
| – | – | 0.01% | 274 |
|
|
2022
Q4 | $23.5K | Hold |
100
| – | – | 0.01% | 319 |
|
|
2022
Q3 | $25K | Hold |
100
| – | – | 0.01% | 285 |
|
|
2022
Q2 | $30K | Hold |
100
| – | – | 0.01% | 266 |
|
|
2022
Q1 | $41K | Hold |
100
| – | – | 0.01% | 252 |
|
|
2021
Q4 | $47K | Buy |
+100
| New | +$47K | 0.01% | 237 |
|
|
2021
Q2 | – | Sell |
-100
| Closed | -$28K | – | 449 |
|
|
2021
Q1 | $28K | Buy |
+100
| New | +$28K | 0.01% | 276 |
|
|
2020
Q4 | – | Sell |
-100
| Closed | -$27K | – | 441 |
|
|
2020
Q3 | $27K | Buy |
+100
| New | +$27K | 0.01% | 248 |
|
|
2019
Q4 | – | Sell |
-100
| Closed | -$14K | – | 501 |
|
|
2019
Q3 | $14K | Buy |
+100
| New | +$14K | 0.01% | 325 |
|